Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab.

Baerlecken, Niklas T

Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab. [electronic resource] - Clinical rheumatology Mar 2013 - S19-20 p. digital

Publication Type: Case Reports; Journal Article

1434-9949

10.1007/s10067-010-1412-8 doi


Adult
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Cryoglobulinemia--complications
Cyclophosphamide--therapeutic use
Drug Substitution
Drug Therapy, Combination
Female
Glucocorticoids--therapeutic use
Humans
Immunologic Factors--therapeutic use
Pulse Therapy, Drug
Remission Induction
Rituximab
Treatment Outcome
Vasculitis, Leukocytoclastic, Cutaneous--complications